Healios K.K.
¥378
12
+¥2+0.53% Today
Statistics
Day High
384
Day Low
373
52W High
747
52W Low
255
Volume
1,355,500
Avg. Volume
3,548,096
Mkt Cap
41.37B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13MayExpected
Expected EPS
-0.07015972
Actual EPS
N/A
Financials
-756.25%Profit Margin
Unprofitable1.12BRevenue
-8.47BNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 4593.TSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mesoblast
MESO
Mkt Cap1.96B
Biolife Solutions
BLFS
Mkt Cap953.44M
CRISPR Therapeutics
CRSP
Mkt Cap4.92B
Editas Medicine
EDIT
Mkt Cap287.74M
Intellia Therapeutics
NTLA
Mkt Cap1.59B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.49B
Sangamo Therapeutics
SGMO
Mkt Cap104.07M
About
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ischemic stroke; and HLCM051, which is in phase 2 clinical trial for the treatment of trauma, as well as HLCR011, which is in phase 1/2 clinical trial for the treatment of retinal pigmen epithelium and age-related macular degeneration and AKT-01/HLCN061, which is in pre-clinical trial for the treatment of Mesothelioma, Lung cancer, Hepatocellular carcinoma and Gastric cancer(solid tumors). It also develops somatic stem cell and induced pluripotent stem cell regenerative medicines. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Chiyoda, Japan.
Show more...
CEO
Dr. Tadahisa S. Kagimoto M.D.
Employees
116
Country
Japan
ISIN
JP3835100003
Listings
0 Comments
Share your thoughts
FAQ
What is Healios K.K. stock price today?▼
The current price of 4593.TSE is ¥378 JPY — it has increased by +0.53% in the past 24 hours. Watch Healios K.K. stock price performance more closely on the chart.
What is Healios K.K. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Healios K.K. stocks are traded under the ticker 4593.TSE.
Is Healios K.K. stock price growing?▼
4593.TSE stock has fallen by -1.05% compared to the previous week, the month change is a -7.8% fall, over the last year Healios K.K. has showed a +41.57% increase.
What is Healios K.K. market cap?▼
Today Healios K.K. has the market capitalization of 41.37B
When is the next Healios K.K. earnings date?▼
Healios K.K. is going to release the next earnings report on May 13, 2026.
What were Healios K.K. earnings last quarter?▼
4593.TSE earnings for the last quarter are 18.52 JPY per share, whereas the estimation was 4.56 JPY resulting in a +306.46% surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Healios K.K. revenue for the last year?▼
Healios K.K. revenue for the last year amounts to 1.12B JPY.
What is Healios K.K. net income for the last year?▼
4593.TSE net income for the last year is -8.47B JPY.
How many employees does Healios K.K. have?▼
As of April 15, 2026, the company has 116 employees.
In which sector is Healios K.K. located?▼
Healios K.K. operates in the Health & Wellness sector.
When did Healios K.K. complete a stock split?▼
Healios K.K. has not had any recent stock splits.
Where is Healios K.K. headquartered?▼
Healios K.K. is headquartered in Tokyo, Japan.